Medtronic Restructuring charges, net increased by 670.0% to $77.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 79.1%, from $43.00M to $77.00M. Over 4 years (FY 2021 to FY 2025), Restructuring charges, net shows relatively stable performance with a -2.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High charges indicate significant organizational change, which may lead to future margin improvements but creates short-term earnings volatility.
Restructuring charges represent costs associated with organizational changes, such as facility consolidations, workforce...
Varies based on corporate strategy; peers undergoing transformation or integration of acquisitions will show higher, periodic restructuring costs.
other_restructuring_charges_net_of_restructuring_reversa_619673| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.00M | $11.00M | $10.00M | $12.00M | $28.00M | $14.00M | $30.00M | $38.00M | $294.00M | $54.00M | $40.00M | $20.00M | $112.00M | $47.00M | $30.00M | $43.00M | $147.00M | $45.00M | $10.00M | $77.00M |
| QoQ Change | — | -81.0% | -9.1% | +20.0% | +133.3% | -50.0% | +114.3% | +26.7% | +673.7% | -81.6% | -25.9% | -50.0% | +460.0% | -58.0% | -36.2% | +43.3% | +241.9% | -69.4% | -77.8% | +670.0% |
| YoY Change | — | — | — | — | -51.7% | +27.3% | +200.0% | +216.7% | +950.0% | +285.7% | +33.3% | -47.4% | -61.9% | -13.0% | -25.0% | +115.0% | +31.3% | -4.3% | -66.7% | +79.1% |